CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- PositionProfit margin is 3.6%, higher than 95% of its Pharmaceutical Retailers peers (median 1.6%)
- FinancialsAltman Z-Score 3.56: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.71%Below 5Y avg (1.20%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
64.1%Moderate
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.46BCNY366.25M · vs all stocks (USD)
Trailing P/E
32.79xvs Pharmaceutical Retailers peers
Revenue (TTM)
2.11BCNY313.90M · vs all stocks (USD)
Profit Margin
3.61%vs Pharmaceutical Retailers peers
Beta
0.3610xvs all stocks
52-Week Change
-15.98%vs all stocks
Market Capitalization
2.46BCNY366.25M · vs all stocks (USD)
Enterprise Value
2.20BCNY327.65M · vs all stocks (USD)
Trailing P/E
32.79xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
1.18xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
2.10xvs Pharmaceutical Retailers peers
Enterprise to Revenue
1.04xvs Pharmaceutical Retailers peers
Gross Margin
14.69%vs Pharmaceutical Retailers peers
Profit Margin
3.61%vs Pharmaceutical Retailers peers
Operating Margin
-0.32%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
-0.37%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
6.61%vs Pharmaceutical Retailers peers
Revenue (TTM)
2.11BCNY313.90M · vs all stocks (USD)
Revenue per Share (TTM)
9.51CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-3.90%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
325.86MCNY48.46M · vs all stocks (USD)
EBITDA (TTM)
29.97MCNY4.46M · vs all stocks (USD)
Net Income (TTM)
76.27MCNY11.34M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
390.90%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
84.53MCNY12.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
26.02MCNY3.87M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0780CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.71%vs all stocks
5-Year Average Dividend Yield
1.20%vs all stocks
Payout Ratio
64.12%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
9.58MCNYFY2025 · Dec 31, 2025Revenue
2.13BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.79BCNYFY2025 · Dec 31, 2025Gross Profit
341.50MCNYFY2025 · Dec 31, 2025Operating Income
8.51MCNY1.27M · vs all stocks (USD)
Pre-tax Income
76.05MCNYFY2025 · Dec 31, 2025Income Tax Expense
17.51MCNYFY2025 · Dec 31, 2025Net Income
58.54MCNYFY2025 · Dec 31, 2025EBIT
80.56MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
102.38MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
68.32MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.51MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
222.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
222.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
58.54MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-789.11KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
21.20MCNYFY2025 · Dec 31, 2025Free Cash Flow
-13.71MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
322.52MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
58.54MCNYFY2025 · Dec 31, 2025Other Non-cash Items
12.98MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-27.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-22.50MCNYFY2025 · Dec 31, 2025Capital Expenditures
34.91MCNYFY2025 · Dec 31, 2025Purchase of Investments
-433.03MCNYFY2025 · Dec 31, 2025Sale of Investments
362.34MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-35.78MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
99.29MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-144.28MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-50.79MCNYFY2025 · Dec 31, 2025Other Financing Charges
-62.39MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-158.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
223.09MSharesUpdated Aug 20, 2026Float Shares
105.20MSharesUpdated Aug 20, 2026% Held by Insiders
52.38%vs all stocks
% Held by Institutions
1.85%vs all stocks
Total Cash (MRQ)
364.81MCNY54.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.64CNYUpdated Aug 20, 2026Total Debt (MRQ)
173.29MCNY25.77M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1454xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.69xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
5.30CNYUpdated Aug 20, 2026Total Assets
2.02BCNY300.59M · vs all stocks (USD)
Total Current Assets
1.06BCNYFY2025 · Dec 31, 2025Total Liabilities
850.46MCNYFY2025 · Dec 31, 2025Total Non-current Assets
964.30MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
183.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
666.49MCNYFY2025 · Dec 31, 2025Cash
95.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
226.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
322.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.03MCNYFY2025 · Dec 31, 2025Accounts Receivable
188.59MCNYFY2025 · Dec 31, 2025Inventory
354.94MCNYFY2025 · Dec 31, 2025Accounts Payable
454.10MCNYFY2025 · Dec 31, 2025Short-term Debt
113.85MCNYFY2025 · Dec 31, 2025Other Current Liabilities
952.24KCNYFY2025 · Dec 31, 2025Long-term Debt
107.82MCNYFY2025 · Dec 31, 2025Common Stock (Book)
223.09MCNYFY2025 · Dec 31, 2025Retained Earnings
583.29MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.17BCNY174.12M · vs all stocks (USD)
52-Week Low
8.83CNYUpdated Aug 20, 202652-Week High
16.05CNYUpdated Aug 20, 202652-Week Change
-15.98%vs all stocks
Beta
0.3610xvs all stocks
50-Day MA
9.99CNYUpdated Aug 20, 2026200-Day MA
11.96CNYUpdated Aug 20, 2026Avg 10-Day Volume
23.32MSharesUpdated Aug 20, 2026Avg 30-Day Volume
10.81MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.3400CNYUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 3.6%, higher than 95% of its Pharmaceutical Retailers peers (median 1.6%)Significant
Profit margin: 0.04Industry median: 0.02Industry P95: 0.04Peers compared: 22.00
Debt-to-equity is 0.15×, lower than 95% of its Pharmaceutical Retailers peers (median 0.7×)Notable
Debt-to-equity: 0.15Industry median: 0.70Industry P5: 0.19Peers compared: 22.00
Financial Health
Altman Z-Score 3.56: safe zoneNotable
Altman Z-Score: 3.56
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Retail Partners Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
VT Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Kits Eyecare Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Lands' End Inc.
Tier 1FlowUnit ReplicationRiskInterface
PTG Energy Public Company Limited
Tier 1FlowUnit ReplicationInterfaceProduction
OceanPact Servicos Maritimos S.A.
Tier 1FlowUnit ReplicationProductionRule
Ministop Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
G-7 Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Card Factory plc
Tier 1FlowUnit ReplicationInterfaceProduction
Yunnan Jianzhi Health Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Mueller Industries Inc.
3 interpretationsPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration
Watsco Inc.
3 interpretationsPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration
Chongqing Road & Bridge Co., Ltd.
3 interpretationsPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration